Faculty

Institution

Unit

Venue

Mehnaz A. Shafi

Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Gastroenterology, Hepatology

Department Of Gastroenterology, Hepatology And Nutrition, 1515 Holcombe Boulevard Unit 1466

The University of Texas MD Anderson Cancer Center

Mehnaz A. Shafi is currently serving as a Gastroenterology, Hepatology Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Mehnaz A. Shafi

The University of Texas MD Anderson Cancer Center

Professor

You can click a keyword to filter the displayed items

gastroenterology oncology gastrointestinal endoscopy medicine pathology digestive endoscopy digestive diseases clinical gastroenterology gastrointestinal surgery gastrointestinal oncology cancer research immunology interventional endoscopy upper gastrointestinal surgery molecular gastroenterology immunotherapy esophagus esophageal cancer colorectal cancer surgical oncology radiology cancer immunotherapy immune checkpoint inhibitors digestive system surgery surgical pathology histopathology gi technique esophageal surgery tumor biology hepatitis patient safety cancer patients bleeding disorders cancer screening cancer genetics cancer genomics ulcerative colitis cancer treatment vascular biology thrombosis vascular surgery molecular cancer transplant infectious diseases stem cell transplantation viral hepatitis lymphoid neoplasia experimental pathology human pathology general pathology delayed gastric emptying united states multiple myeloma brain tumor research oncogenes cancer cells clinical guidance vascular trauma blood transfusion molecular pathology graft rejection liver disease acute liver failure wound assessment gynecological surgery clinical guideline complex colon polyps detection rates premalignant polyps quality standards oncologic therapy clinical features rituximab-associated gastrointestinal toxicities argon plasma coagulation gi tumors mutational profiles reveal colon adenomas

Notable Scholarly Works

Notable Federal Grants

Collaborators

Gastrointestinal Adverse Events Following Brentuximab Vedotin and Polatuzumab Vedotin Therapy. Therapeutic Advances in Medical Oncology (2026)

digestive diseasesmedicineclinical gastroenterologypharmacologybrentuximab vedotinpharmacotherapyclinical researchgastroenterology

Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis From Cancer Immunotherapy. Targeted Oncology (2025)

immunologydigestive diseasesmedicineimmune checkpoint inhibitorscancer immunotherapymolecular gastroenterologyoncologygastroenterologyproton pump inhibitorsimmune-mediated gastroenteritisimmunosuppressionimmunotherapy

Clinical Characteristics of Cancer-Associated Achalasia (Caa): A 25-Year Review From a Cancer Hospital.. Journal of Clinical Oncology (2025)

cancer-associated achalasiacancer hospitaloncology25-year reviewlung cancerpathology

Constipation Following Immune Checkpoint Inhibitor Therapy. Current Treatment Options in Gastroenterology (2025)

immunologydigestive diseasescancer immunotherapygastrointestinal pharmacologyfunctional gastrointestinal disordersgastroenterologyimmunotherapy

Diverticulitis Post Immune Checkpoint Inhibitor Therapy. (2025)

immunologyimmune checkpoint inhibitorscancer immunotherapyimmunomodulationimmunosuppressioncellular therapyexperimental medicineimmunotherapy

Endoscopic Treatment With Mucosal Resection, Radiofrequency Ablation, and Cryotherapy is Safe and Effective in the Curative Treatment of Early Esophageal Squamous Cell Cancer and Squamous Cell Dysplasia. Gastrointestinal Endoscopy (2025)

surgeryesophagusinterventional endoscopyradiation oncologysurgical oncologyesophageal surgeryradiofrequency ablationoncologygastroenterologygastrointestinal endoscopyesophageal cancer

Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis. Cancer Medicine (2025)

immunologydigestive diseasesinfection controlmucosal immunologyulcerative colitisgastroenterologyimmune responsesinfectious diseasesinflammatory diseasesimmunity (medicine)gastrointestinal infectionimmunotherapyinflammatory bowel disease

Illustrative Cases in Onco-Neurogastroenterology. (2025)

digestive diseasesclinical gastroenterologyanatomical pathologyabdominal imagingneuropathologydiagnosisgastrointestinal surgeryhistopathologydigestive system surgerygastroenterologyillustrative casespathologygastrointestinal endoscopy

Impact of a Structured 12-Week Education Program to Standardize Endoscopy Nurse Training. Gastrointestinal Endoscopy (2025)

program evaluationsurgical trainingnurse educationinterventional endoscopyhealth profession trainingnursingeducationcontinuing medical educationdigestive endoscopyclinical nursingmedical educationgastrointestinal endoscopy

Long-Term Durability of Endoscopic Eradication Therapy of Barrett’s Esophagus and Early Esophageal Adenocarcinoma Using Endoscopic Mucosal Resection, Radiofrequency Ablation or Cryotherapy. Gastrointestinal Endoscopy (2025)

surgeryesophagusinterventional endoscopyradiation oncologyesophageal surgeryoncologygastroenterologydigestive endoscopygastrointestinal endoscopyesophageal cancer

1
2
3
4
5
12
10 / page

Mehnaz A. Shafi

Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Gastroenterology, Hepatology

Department Of Gastroenterology, Hepatology And Nutrition, 1515 Holcombe Boulevard Unit 1466

The University of Texas MD Anderson Cancer Center

Mehnaz A. Shafi is currently serving as a Gastroenterology, Hepatology Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Mehnaz A. Shafi

The University of Texas MD Anderson Cancer Center

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Gastrointestinal Adverse Events Following Brentuximab Vedotin and Polatuzumab Vedotin Therapy. Therapeutic Advances in Medical Oncology (2026)

digestive diseasesmedicineclinical gastroenterologypharmacologybrentuximab vedotinpharmacotherapyclinical researchgastroenterology

Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis From Cancer Immunotherapy. Targeted Oncology (2025)

Clinical Characteristics of Cancer-Associated Achalasia (Caa): A 25-Year Review From a Cancer Hospital.. Journal of Clinical Oncology (2025)

cancer-associated achalasiacancer hospitaloncology25-year reviewlung cancerpathology

Constipation Following Immune Checkpoint Inhibitor Therapy. Current Treatment Options in Gastroenterology (2025)

immunologydigestive diseasescancer immunotherapygastrointestinal pharmacologyfunctional gastrointestinal disordersgastroenterologyimmunotherapy

Diverticulitis Post Immune Checkpoint Inhibitor Therapy. (2025)

immunologyimmune checkpoint inhibitorscancer immunotherapyimmunomodulationimmunosuppressioncellular therapyexperimental medicineimmunotherapy

surgeryesophagusinterventional endoscopyradiation oncologysurgical oncologyesophageal surgeryradiofrequency ablationoncologygastroenterologygastrointestinal endoscopyesophageal cancer

Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis. Cancer Medicine (2025)

Illustrative Cases in Onco-Neurogastroenterology. (2025)

Impact of a Structured 12-Week Education Program to Standardize Endoscopy Nurse Training. Gastrointestinal Endoscopy (2025)

surgeryesophagusinterventional endoscopyradiation oncologyesophageal surgeryoncologygastroenterologydigestive endoscopygastrointestinal endoscopyesophageal cancer

1
2
3
4
5
12
10 / page